You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: November 25, 2024

~ Buy the KOVANAZE (oxymetazoline hydrochloride; tetracaine hydrochloride) Drug Profile, 2024 PDF Report in the Report Store ~

CLINICAL TRIALS PROFILE FOR KOVANAZE


✉ Email this page to a colleague

« Back to Dashboard


All Clinical Trials for KOVANAZE

Trial ID Title Status Sponsor Phase Start Date Summary
NCT03368391 ↗ : Pulpal Blood Flow With the Use of Intra-nasal Anesthetic Unknown status Louisiana State University Health Sciences Center in New Orleans Phase 4 2018-01-03 Anesthetics with vasoconstrictors decrease pulpal blood flow but the impact of intranasal local anesthetics on blood flow is unknown. This blinded, randomized crossover clinical trial will compare the effects of different local anesthetics on anterior teeth in healthy volunteers. On separate study visits patients will receive either traditional injections or intranasal administration of the following solutions: 2% lidocaine with 1:100,000 epi, 3% mepivacaine, tetracaine HCl and oxymetazoline HCl, or saline. The following variables will be assessed: pulpal blood flow, pulpal sensibility, pain on administration, and adverse outcomes.
NCT03502135 ↗ Efficacy of Tetracaine/Oxymetazoline Nasal Spray for Endodontic Treatment Withdrawn University of North Carolina, Chapel Hill Phase 4 2018-09-01 Purpose: To evaluate anesthetic efficacy and overall patient experience with use of Kovanaze tetracaine/oxymetazoline nasal spray for root canal treatment of vital premolar and anterior teeth needing root canal treatment. Participants: 30 adult patients with a vital upper anterior or premolar tooth (#4-13) with a diagnosis indicating need root canal treatment and who are seeking treatment in the UNC Chapel Hill School of Dentistry. Procedures (methods): Qualifying patients will be anesthetized with tetracaine/oxymetazoline nasal spray anesthetic in order to facilitate completion of their clinically required, standard of care root canal treatment. Research procedures include blood pressure monitoring and pain assessment using a visual analogue pain scale.
NCT03962634 ↗ Kovanaze Vs. Articaine in Achieving Pulpal Anesthesia of Maxillary Teeth - Pediatric Terminated Virginia Commonwealth University Phase 2 2019-08-28 The primary goal of the study is to compare the success rates of pulpal anesthesia (defined as ability to complete the intended dental procedure without the need for rescue anesthesia) between Kovanaze nasal mist and Articaine needle anesthesia.
NCT04104789 ↗ Kovanaze Vs. Articaine in Achieving Pulpal Anesthesia of Maxillary Teeth - General Withdrawn Virginia Commonwealth University Phase 2 2020-09-01 The primary goal of the study is to compare the success rates of pulpal anesthesia (defined as ability to complete the intended dental procedure without the need for rescue anesthesia) between Kovanaze nasal mist and Articaine needle anesthesia.
NCT04105985 ↗ Kovanaze Vs. Articaine in Achieving Pulpal Anesthesia of Maxillary Teeth - Endodontics Withdrawn Virginia Commonwealth University Phase 2 2020-08-01 The primary goal of the study is to compare the success rates of pulpal anesthesia (defined as ability to complete the intended dental procedure without the need for rescue anesthesia) between Kovanaze nasal mist and Articaine needle anesthesia.
>Trial ID >Title >Status >Phase >Start Date >Summary

Clinical Trial Conditions for KOVANAZE

Condition Name

Condition Name for KOVANAZE
Intervention Trials
Apical Periodontitis 3
Caries,Dental 3
Local Anesthetic Drug Adverse Reaction 1
Local Infiltration 1
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Condition MeSH

Condition MeSH for KOVANAZE
Intervention Trials
Periodontitis 3
Periapical Periodontitis 3
Dental Caries 3
Dental Pulp Diseases 2
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Locations for KOVANAZE

Trials by Country

Trials by Country for KOVANAZE
Location Trials
United States 4
This preview shows a limited data set
Subscribe for full access, or try a Trial

Trials by US State

Trials by US State for KOVANAZE
Location Trials
Virginia 3
North Carolina 1
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Progress for KOVANAZE

Clinical Trial Phase

Clinical Trial Phase for KOVANAZE
Clinical Trial Phase Trials
Phase 4 2
Phase 2 3
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Status

Clinical Trial Status for KOVANAZE
Clinical Trial Phase Trials
Withdrawn 3
Terminated 1
Unknown status 1
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Sponsors for KOVANAZE

Sponsor Name

Sponsor Name for KOVANAZE
Sponsor Trials
Virginia Commonwealth University 3
Louisiana State University Health Sciences Center in New Orleans 1
University of North Carolina, Chapel Hill 1
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Sponsor Type

Sponsor Type for KOVANAZE
Sponsor Trials
Other 5
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.